{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:51:30Z","timestamp":1776408690361,"version":"3.51.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Second Hospital of Dalian Medical University","award":["GXFK202504"],"award-info":[{"award-number":["GXFK202504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06935-z","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:46:01Z","timestamp":1773467161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The novel ETV6::RARA fusion gene, identified in acute promyelocytic leukemia, is sensitive to invitro all-tans retinoic acid and arsenic trioxide administrations"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-7947","authenticated-orcid":false,"given":"Mohammad Arian","family":"Hassani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4109-2602","authenticated-orcid":false,"given":"Jinsong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"issue":"2","key":"6935_CR1","first-page":"57","volume":"97","author":"AA Cooperberg","year":"1967","unstructured":"Cooperberg AA (1967) Acute promyelocytic leukemia. Can Med Assoc J 97(2):57\u201363","journal-title":"Can Med Assoc J"},{"key":"6935_CR2","doi-asserted-by":"publisher","unstructured":"Liquori A, Iba\u00f1ez M, Sargas C, Sanz M, Barrag\u00e1n E, Cervera J (2020) Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers (Basel) 12(3). https:\/\/doi.org\/10.3390\/cancers12030624","DOI":"10.3390\/cancers12030624"},{"issue":"1","key":"6935_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40364-021-00284-x","volume":"9","author":"X Zhang","year":"2021","unstructured":"Zhang X, Sun J, Yu W, Jin J (2021) Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark Res 9(1):33. https:\/\/doi.org\/10.1186\/s40364-021-00284-x","journal-title":"Biomark Res"},{"key":"6935_CR4","doi-asserted-by":"publisher","unstructured":"Sobas M, Talarn-Forcadell MC, Mart\u00ednez-Cuadr\u00f3n D, Escoda L, Garc\u00eda-P\u00e9rez MJ, Mariz J et al (2020) PLZF-RAR(\u03b1), NPM1-RAR(\u03b1), and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review. Cancers (Basel) 12(5). https:\/\/doi.org\/10.3390\/cancers12051313","DOI":"10.3390\/cancers12051313"},{"key":"6935_CR5","doi-asserted-by":"publisher","first-page":"1062524","DOI":"10.3389\/fonc.2022.1062524","volume":"12","author":"SG Iyer","year":"2022","unstructured":"Iyer SG, Elias L, Stanchina M, Watts J (2022) The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions. Front Oncol 12:1062524. https:\/\/doi.org\/10.3389\/fonc.2022.1062524","journal-title":"Front Oncol"},{"key":"6935_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.12.003","volume":"41","author":"A di Masi","year":"2015","unstructured":"di Masi A, Leboffe L, De Marinis E, Pagano F, Cicconi L, Rochette-Egly C et al (2015) Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Aspects Med 41:1\u2013115. https:\/\/doi.org\/10.1016\/j.mam.2014.12.003","journal-title":"Mol Aspects Med"},{"issue":"8","key":"6935_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","volume":"36","author":"E De Braekeleer","year":"2012","unstructured":"De Braekeleer E, Douet-Guilbert N, Morel F, Le Bris MJ, Basinko A, De Braekeleer M (2012) ETV6 fusion genes in hematological malignancies: a review. Leuk Res 36(8):945\u2013961. https:\/\/doi.org\/10.1016\/j.leukres.2012.04.010","journal-title":"Leuk Res"},{"issue":"1","key":"6935_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12935-022-02451-y","volume":"22","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wang F, Yan F, Huang D, Wang H, Gao B et al (2022) Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway. Cancer Cell Int 22(1):40. https:\/\/doi.org\/10.1186\/s12935-022-02451-y","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6935_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.stem.2020.04.005","volume":"27","author":"K Rothe","year":"2020","unstructured":"Rothe K, Babaian A, Nakamichi N, Chen M, Chafe SC, Watanabe A et al (2020) Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors. Cell Stem Cell 27(1):110\u201324e9. https:\/\/doi.org\/10.1016\/j.stem.2020.04.005","journal-title":"Cell Stem Cell"},{"issue":"3","key":"6935_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0092-8674(93)80044-f","volume":"74","author":"F Grignani","year":"1993","unstructured":"Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M et al (1993) The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74(3):423\u2013431. https:\/\/doi.org\/10.1016\/0092-8674(93)80044-f","journal-title":"Cell"},{"issue":"1","key":"6935_CR11","doi-asserted-by":"publisher","first-page":"9414","DOI":"10.1038\/s41598-019-45982-7","volume":"9","author":"TT Huynh","year":"2019","unstructured":"Huynh TT, Sultan M, Vidovic D, Dean CA, Cruickshank BM, Lee K et al (2019) Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells. Sci Rep 9(1):9414. https:\/\/doi.org\/10.1038\/s41598-019-45982-7","journal-title":"Sci Rep"},{"issue":"7","key":"6935_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.189.7.1043","volume":"189","author":"V Lallemand-Breitenbach","year":"1999","unstructured":"Lallemand-Breitenbach V, Guillemin MC, Janin A, Daniel MT, Degos L, Kogan SC et al (1999) Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia. J Exp Med 189(7):1043\u20131052. https:\/\/doi.org\/10.1084\/jem.189.7.1043","journal-title":"J Exp Med"},{"issue":"2","key":"6935_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1182\/blood.V72.2.691.691","volume":"72","author":"MA Socinski","year":"1988","unstructured":"Socinski MA, Cannistra SA, Sullivan R, Elias A, Antman K, Schnipper L et al (1988) Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. Blood 72(2):691\u2013697","journal-title":"Blood"},{"issue":"1","key":"6935_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1182\/blood.V73.1.131.131","volume":"73","author":"AG Rosmarin","year":"1989","unstructured":"Rosmarin AG, Weil SC, Rosner GL, Griffin JD, Arnaout MA, Tenen DG (1989) Differential expression of CD11b\/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood 73(1):131\u2013136","journal-title":"Blood"},{"issue":"2","key":"6935_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/cam4.579","volume":"5","author":"Y Jin","year":"2016","unstructured":"Jin Y, Wang X, Hu S, Tang J, Li B, Chai Y (2016) Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing. Cancer Med 5(2):337\u2013351. https:\/\/doi.org\/10.1002\/cam4.579","journal-title":"Cancer Med"},{"issue":"1","key":"6935_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41467-025-56229-7","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Zhao H, Yang W, Maillard M, Yoshimura S, Hsiao Y-C et al (2025) Molecular and pharmacological heterogeneity of ETV6::RUNX1 acute lymphoblastic leukemia. Nat Commun 16(1):1153. https:\/\/doi.org\/10.1038\/s41467-025-56229-7","journal-title":"Nat Commun"},{"issue":"2","key":"6935_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.4143\/crt.2016.211","volume":"49","author":"JW Lee","year":"2017","unstructured":"Lee JW, Kim SK, Jang PS, Chung NG, Jeong DC, Kim M et al (2017) Outcome and Prognostic Factors for ETV6\/RUNX1 Positive Pediatric Acute Lymphoblastic Leukemia Treated at a Single Institution in Korea. Cancer Res Treat 49(2):446\u2013453. https:\/\/doi.org\/10.4143\/crt.2016.211","journal-title":"Cancer Res Treat"},{"key":"6935_CR18","doi-asserted-by":"publisher","first-page":"101667","DOI":"10.1016\/j.bbrep.2024.101667","volume":"38","author":"Q Li","year":"2024","unstructured":"Li Q, Wang F, Zhang X, Liu S, Sun MZ, Yan J (2024) The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells. Biochem Biophys Rep 38:101667. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101667","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"6935_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41379-020-00663-z","volume":"34","author":"A Ronaghy","year":"2021","unstructured":"Ronaghy A, Hu S, Tang Z, Wang W, Tang G, Loghavi S et al (2021) Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities. Mod Pathol 34(2):300\u2013313. https:\/\/doi.org\/10.1038\/s41379-020-00663-z","journal-title":"Mod Pathol"},{"issue":"2","key":"6935_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bbrc.2006.06.127","volume":"347","author":"T Yamagata","year":"2006","unstructured":"Yamagata T, Maki K, Waga K, Mitani K (2006) TEL\/ETV6 induces apoptosis in 32D cells through p53-dependent pathways. Biochem Biophys Res Commun 347(2):517\u2013526. https:\/\/doi.org\/10.1016\/j.bbrc.2006.06.127","journal-title":"Biochem Biophys Res Commun"},{"issue":"28","key":"6935_CR21","doi-asserted-by":"publisher","first-page":"17525","DOI":"10.1074\/jbc.273.28.17525","volume":"273","author":"BA Kwiatkowski","year":"1998","unstructured":"Kwiatkowski BA, Bastian LS, Bauer TR Jr., Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD (1998) The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem 273(28):17525\u201317530. https:\/\/doi.org\/10.1074\/jbc.273.28.17525","journal-title":"J Biol Chem"},{"issue":"16","key":"6935_CR22","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1128\/mcb.20.16.5828-5839.2000","volume":"20","author":"R Fenrick","year":"2000","unstructured":"Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J et al (2000) TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Mol Cell Biol 20(16):5828\u20135839. https:\/\/doi.org\/10.1128\/mcb.20.16.5828-5839.2000","journal-title":"Mol Cell Biol"},{"issue":"42","key":"6935_CR23","doi-asserted-by":"publisher","first-page":"30132","DOI":"10.1074\/jbc.274.42.30132","volume":"274","author":"RG Lopez","year":"1999","unstructured":"Lopez RG, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J (1999) TEL is a sequence-specific transcriptional repressor. J Biol Chem 274(42):30132\u201330138. https:\/\/doi.org\/10.1074\/jbc.274.42.30132","journal-title":"J Biol Chem"},{"issue":"2","key":"6935_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-022-01059-8","volume":"25","author":"DY Lu","year":"2023","unstructured":"Lu DY, Ellegast JM, Ross KN, Malone CF, Lin S, Mabe NW et al (2023) The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma. Nat Cell Biol 25(2):285\u2013297. https:\/\/doi.org\/10.1038\/s41556-022-01059-8","journal-title":"Nat Cell Biol"},{"issue":"2","key":"6935_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1053\/j.seminhematol.2017.04.005","volume":"54","author":"H Hock","year":"2017","unstructured":"Hock H, Shimamura A (2017) ETV6 in hematopoiesis and leukemia predisposition. Semin Hematol 54(2):98\u2013104. https:\/\/doi.org\/10.1053\/j.seminhematol.2017.04.005","journal-title":"Semin Hematol"},{"issue":"6","key":"6935_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood-2013-10-528596","volume":"124","author":"Y Chen","year":"2014","unstructured":"Chen Y, Li S, Zhou C, Li C, Ru K, Rao Q et al (2014) TBLR1 fuses to retinoid acid receptor \u03b1 in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia. Blood 124(6):936\u2013945. https:\/\/doi.org\/10.1182\/blood-2013-10-528596","journal-title":"Blood"},{"issue":"11","key":"6935_CR27","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1182\/blood.2020005698","volume":"137","author":"Y Tan","year":"2021","unstructured":"Tan Y, Wang X, Song H, Zhang Y, Zhang R, Li S et al (2021) A PML\/RAR\u03b1 direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia. Blood 137(11):1503\u20131516. https:\/\/doi.org\/10.1182\/blood.2020005698","journal-title":"Blood"},{"issue":"18","key":"6935_CR28","doi-asserted-by":"publisher","first-page":"e2317690121","DOI":"10.1073\/pnas.2317690121","volume":"121","author":"CDS Katerndahl","year":"2024","unstructured":"Katerndahl CDS, Rogers ORS, Day RB, Xu Z, Helton NM, Ramakrishnan SM et al (2024) PML::RARA and GATA2 proteins interact via DNA templates to induce aberrant self-renewal in mouse and human hematopoietic cells. Proc Natl Acad Sci U S A 121(18):e2317690121. https:\/\/doi.org\/10.1073\/pnas.2317690121","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6935_CR29","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1038\/s41467-025-57096-y","volume":"16","author":"H Komic","year":"2025","unstructured":"Komic H, Schmachtel T, Simoes C, K\u00fclp M, Yu W, Jolly A et al (2025) Continuous map of early hematopoietic stem cell differentiation across human lifetime. Nat Commun 16(1):2287. https:\/\/doi.org\/10.1038\/s41467-025-57096-y","journal-title":"Nat Commun"},{"issue":"8","key":"6935_CR30","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3324\/haematol.2014.123018","volume":"100","author":"C Gaillard","year":"2015","unstructured":"Gaillard C, Tokuyasu TA, Rosen G, Sotzen J, Vitaliano-Prunier A, Roy R et al (2015) Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML\/RARA in leukemia initiation. Haematologica 100(8):1064\u20131075. https:\/\/doi.org\/10.3324\/haematol.2014.123018","journal-title":"Haematologica"},{"key":"6935_CR31","doi-asserted-by":"publisher","first-page":"1049473","DOI":"10.3389\/fonc.2022.1049473","volume":"12","author":"G Liu","year":"2022","unstructured":"Liu G, Long J, Chen Y, Li L, Huan X, Long P (2022) Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses. Front Oncol 12:1049473. https:\/\/doi.org\/10.3389\/fonc.2022.1049473","journal-title":"Front Oncol"},{"key":"6935_CR32","doi-asserted-by":"publisher","first-page":"116646","DOI":"10.1016\/j.bcp.2024.116646","volume":"231","author":"P Garg","year":"2025","unstructured":"Garg P, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS (2025) Exploring the potential of TGF\u03b2 as a diagnostic marker and therapeutic target against cancer. Biochem Pharmacol 231:116646. https:\/\/doi.org\/10.1016\/j.bcp.2024.116646","journal-title":"Biochem Pharmacol"},{"key":"6935_CR33","doi-asserted-by":"publisher","unstructured":"Cecerska-Hery\u0107 E, Jerzyk A, Goszka M, Polikowska A, Rachwalska J, Serwin N et al (2025) TGF-\u03b2 Signaling in Cancer: Mechanisms of Progression and Therapeutic Targets. Int J Mol Sci 26(15). https:\/\/doi.org\/10.3390\/ijms26157326","DOI":"10.3390\/ijms26157326"},{"issue":"12","key":"6935_CR34","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1002\/1878-0261.13215","volume":"16","author":"Y Tsubakihara","year":"2022","unstructured":"Tsubakihara Y, Ohata Y, Okita Y, Younis S, Eriksson J, Sellin ME et al (2022) TGF\u03b2 selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition. Mol Oncol 16(12):2330\u20132354. https:\/\/doi.org\/10.1002\/1878-0261.13215","journal-title":"Mol Oncol"},{"key":"6935_CR35","doi-asserted-by":"publisher","unstructured":"Cuevas D, Amigo R, Agurto A, Heredia AA, Guzm\u00e1n C, Recabal-Beyer A et al (2024) The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression. Biomedicines 12(8). https:\/\/doi.org\/10.3390\/biomedicines12081915","DOI":"10.3390\/biomedicines12081915"},{"issue":"12","key":"6935_CR36","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1038\/s41375-023-02054-0","volume":"37","author":"T Ottone","year":"2023","unstructured":"Ottone T, Silvestrini G, Piazza R, Travaglini S, Gurnari C, Marchesi F et al (2023) Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways. Leukemia 37(12):2383\u20132394. https:\/\/doi.org\/10.1038\/s41375-023-02054-0","journal-title":"Leukemia"},{"issue":"1","key":"6935_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1182\/bloodadvances.2021004962","volume":"6","author":"S Stratmann","year":"2022","unstructured":"Stratmann S, Yones SA, Garbulowski M, Sun J, Skaftason A, Mayrhofer M et al (2022) Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Adv 6(1):152\u2013164. https:\/\/doi.org\/10.1182\/bloodadvances.2021004962","journal-title":"Blood Adv"},{"key":"6935_CR38","doi-asserted-by":"publisher","first-page":"7239206","DOI":"10.1155\/2019\/7239206","volume":"2019","author":"L Handschuh","year":"2019","unstructured":"Handschuh L (2019) Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies. J Oncol 2019:7239206. https:\/\/doi.org\/10.1155\/2019\/7239206","journal-title":"J Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06935-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:59:19Z","timestamp":1776405559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6935"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06935-z","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical committee of the Second Hospital of Dalian Medical University number: 2020040.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}